Aktienanalyse wird geladen …
SYK · NYSE · Medical Devices · USA
272,36 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 25,12 Mrd. | 3,25 Mrd. | 8,40 $ | 386,5 Mio. | 0,9 Mio · 0,2 % | — | 64 % | 12,9 % | 11,08 $ | 0,63 $ | 3,40 $ |
| 2024 | 22,6 Mrd. | 2,99 Mrd. | 7,76 $ | 385,6 Mio. | 0,8 Mio · 0,2 % | — | 63,9 % | 13,3 % | 9,04 $ | 0,59 $ | 3,24 $ |
| 2023 | 20,5 Mrd. | 3,17 Mrd. | 8,25 $ | 383,7 Mio. | 0,8 Mio · 0,2 % | — | 63,7 % | 15,4 % | 8,17 $ | 0,53 $ | 3,05 $ |
| 2022 | 18,45 Mrd. | 2,36 Mrd. | 6,17 $ | 382,2 Mio. | 0,6 Mio · 0,2 % | 0,7 Mio · 0,2 % | 62,8 % | 12,8 % | 5,33 $ | 0,44 $ | 2,84 $ |
| 2021 | 17,11 Mrd. | 1,99 Mrd. | 5,21 $ | 382,3 Mio. | 0,6 Mio · 0,2 % | — | 64,1 % | 11,7 % | 7,16 $ | 0,45 $ | 2,59 $ |
| 2020 | 14,35 Mrd. | 1,6 Mrd. | 4,20 $ | 380,3 Mio. | 0,5 Mio · 0,1 % | 0,1 Mio · 0 % | 63,1 % | 11,1 % | 7,34 $ | 0,37 $ | 2,36 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 6,59 Mrd. | 1,28 Mrd. | 3,31 $ | 386 Mio. | 68,3 % | 19,4 % | 2,74 $ |
| Q1 2026 | 6,02 Mrd. | 745 Mio. | 1,93 $ | 386,5 Mio. | 63,3 % | 12,4 % | 1,07 $ |
| Q4 2025 | 7,17 Mrd. | 849 Mio. | 2,20 $ | 386,5 Mio. | 64,5 % | 11,8 % | 4,85 $ |
| Q3 2025 | 6,06 Mrd. | 859 Mio. | 2,22 $ | 386,7 Mio. | 63,6 % | 14,2 % | 3,50 $ |
| Q2 2025 | 6,02 Mrd. | 884 Mio. | 2,29 $ | 386,4 Mio. | 63,8 % | 14,7 % | 2,40 $ |
| Q1 2025 | 5,87 Mrd. | 654 Mio. | 1,69 $ | 386,4 Mio. | 63,8 % | 11,2 % | 0,33 $ |
| Q4 2024 | 6,44 Mrd. | 546 Mio. | 1,41 $ | — | 64,9 % | 8,5 % | 4,31 $ |
| Q3 2024 | 5,49 Mrd. | 834 Mio. | 2,16 $ | 385,6 Mio. | 64 % | 15,2 % | 3,38 $ |
ELFA Names James Cress Acting President & CEO
Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
What Does General Dynamics (GD) Winning New Stryker Work Mean Through 2028?
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?
Can Stryker Vehicle Demand Support General Dynamics' Growth?
Stryker Corp. is a medical technology company focused on products and services that support patient care and healthcare delivery. The company operates across MedSurg, Neurotechnology, and Orthopaedics, supplying hospitals, surgeons, and other healthcare providers with surgical equipment, endoscopic and communications systems, patient handling tools, emergency medical equipment, implantable devices, and neurovascular solutions. Its orthopaedics business includes implants used in joint replacement, trauma, and extremities procedures, while its medical and surgical portfolio addresses operating room efficiency, clinical workflows, and perioperative care. Stryker Corp. plays an important role in the global healthcare market by providing technologies that are used in surgery, acute care, and orthopedic treatment across a wide range of clinical settings.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest SYK und jede andere Aktie unbegrenzt.